Sale!

Biopsy Breast Modified Radical Mastectomy ER PR

Original price was: $226.Current price is: $168.

-26%

The Biopsy Breast Modified Radical Mastectomy ER PR test is a comprehensive diagnostic procedure that analyzes breast tissue following modified radical mastectomy surgery. This advanced histopathology examination evaluates estrogen receptor (ER) and progesterone receptor (PR) status, which are critical biomarkers for determining breast cancer treatment strategies. The test provides essential information about hormone receptor expression, helping oncologists develop personalized treatment plans including hormone therapy options. With results available in just 6 days and a discounted price of $168 USD, this test offers valuable insights for patients undergoing breast cancer treatment. Our nationwide network of testing facilities ensures convenient access across all major US cities.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

Biopsy Breast Modified Radical Mastectomy ER PR Test

Comprehensive Breast Cancer Analysis and Receptor Status Evaluation

The Biopsy Breast Modified Radical Mastectomy ER PR test represents a crucial diagnostic advancement in breast cancer management. This specialized histopathology examination provides detailed analysis of breast tissue specimens obtained during modified radical mastectomy procedures, offering comprehensive insights into tumor characteristics and hormone receptor status that are essential for developing effective treatment strategies.

What This Test Measures and Detects

This sophisticated diagnostic test evaluates multiple critical components of breast cancer pathology:

  • Estrogen Receptor (ER) Status: Determines whether cancer cells have receptors for estrogen, indicating potential responsiveness to hormone therapy
  • Progesterone Receptor (PR) Status: Assesses the presence of progesterone receptors, another key biomarker for hormone-sensitive cancers
  • Tissue Architecture: Analyzes the microscopic structure of breast tissue following mastectomy
  • Surgical Margins: Evaluates the completeness of tumor removal and margin status
  • Lymph Node Involvement: Assesses potential cancer spread to regional lymph nodes

Who Should Consider This Test

This comprehensive analysis is particularly important for patients who:

  • Have undergone modified radical mastectomy for breast cancer treatment
  • Require detailed hormone receptor status determination for treatment planning
  • Need confirmation of complete tumor removal and margin assessment
  • Are candidates for hormone therapy based on receptor status
  • Require comprehensive pathological staging following surgical intervention

Clinical Benefits and Importance

The Biopsy Breast Modified Radical Mastectomy ER PR test offers numerous clinical advantages:

  • Personalized Treatment Planning: Hormone receptor status directly influences treatment decisions, including eligibility for hormone-blocking therapies
  • Prognostic Information: ER and PR status provide valuable insights into disease progression and recurrence risk
  • Therapeutic Guidance: Results help oncologists determine the most effective treatment combinations
  • Surgical Outcome Assessment: Confirms the completeness of cancer removal and evaluates surgical margins
  • Comprehensive Staging: Provides essential information for accurate cancer staging and follow-up planning

Understanding Your Test Results

Your test results will provide detailed information about:

  • ER Status: Positive results indicate potential responsiveness to estrogen-blocking medications, while negative results suggest alternative treatment approaches may be more effective
  • PR Status: Similar to ER status, positive PR results may indicate benefit from progesterone-targeted therapies
  • Surgical Margins: Clear margins suggest complete tumor removal, while positive margins may require additional treatment
  • Lymph Node Status: Information about whether cancer has spread to regional lymph nodes
  • Tumor Characteristics: Detailed description of tumor type, grade, and other pathological features

Test Details and Pricing

Test Component Details
Test Name Biopsy Breast Modified Radical Mastectomy ER PR
Regular Price $226 USD
Discount Price $168 USD
Turnaround Time 6 Days
Sample Type Tissue
Test Components Tissue in 10% Neutral Buffered Formalin
Specialty General Surgeon
Method Histopathology

Pre-Test Instructions

The Biopsy Breast Modified Radical Mastectomy ER PR test requires a Doctor’s prescription. Please note that prescription requirements do not apply to surgery and pregnancy cases or individuals planning to travel abroad. Our experienced team will guide you through the preparation process and ensure all necessary documentation is complete.

Nationwide Accessibility

We have branches across all major cities in the United States, including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our nationwide network ensures convenient access to this essential diagnostic service regardless of your location.

Take Control of Your Breast Cancer Journey

Understanding your breast cancer receptor status is crucial for developing the most effective treatment plan. The Biopsy Breast Modified Radical Mastectomy ER PR test provides the comprehensive information needed to make informed decisions about your care. With our discounted price of $168 USD and fast 6-day turnaround, you can access this vital diagnostic information quickly and affordably.

Ready to schedule your test? Call or WhatsApp us today at +1(267) 388-9828 to book your appointment and take the next step in your breast cancer treatment journey.